Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Imig

Showing results (51-60 of 193) with videos related to

Pageof 20
Sort By:
American Journal of Physiology. Renal Physiology|November 13, 2009
Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertensionSarah F Knight, Jianghe Yuan, Siddhartha Roy, et al.
International Journal of Experimental Diabetes Research|May 7, 2002
Renal AT1 receptor protein expression during the early stage of diabetes mellitusLisa M Harrison-Bernard, John D Imig, Pamela K Carmines
Frontiers in Physiology|April 11, 2022
Editorial: Interactions Between Podocytes, Mesangial Cells, and Glomerular Endothelial Cells in Glomerular DiseasesJohn D Imig, Xueying Zhao, Ahmed A Elmarakby, et al.
Journal of Lipid Research|September 3, 2003
12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channelsShih Shen Yiu, Xueying Zhao, Edward W Inscho, et al.
Hypertension (Dallas, Tex. : 1979)|August 6, 2003
Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenasesXueying Zhao, David M Pollock, Darryl C Zeldin, et al.
Expert Reviews in Molecular Medicine|March 2, 2011
Cytochrome P450 eicosanoids and cerebral vascular functionJohn D Imig, Alexis N Simpkins, Marija Renic, et al.
Current Opinion in Nephrology and Hypertension|November 30, 2021
Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosisKate C Chiang, John D Imig, Kamyar Kalantar-Zadeh, et al.
American Journal of Hypertension|March 7, 2014
Azilsartan improves glycemic status and reduces kidney damage in zucker diabetic fatty ratsMd Abdul Hye Khan, Jan Neckář, Jasmine Haines, et al.
Journal of Hypertension|May 6, 2004
Elevated arterial pressure impairs autoregulation independently of AT(1) receptor activationEdward W Inscho, Anthony K Cook, James B Murzynowski, et al.
Hypertension (Dallas, Tex. : 1979)|January 18, 2006
Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertensionAhmed A Elmarakby, Jeffrey E Quigley, David M Pollock, et al.
Pageof 20

Showing results (51-60 of 193) with videos related to

Sort By:
Pageof 20
American Journal of Physiology. Renal Physiology|November 13, 2009
Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertensionSarah F Knight, Jianghe Yuan, Siddhartha Roy, et al.
International Journal of Experimental Diabetes Research|May 7, 2002
Renal AT1 receptor protein expression during the early stage of diabetes mellitusLisa M Harrison-Bernard, John D Imig, Pamela K Carmines
Frontiers in Physiology|April 11, 2022
Editorial: Interactions Between Podocytes, Mesangial Cells, and Glomerular Endothelial Cells in Glomerular DiseasesJohn D Imig, Xueying Zhao, Ahmed A Elmarakby, et al.
Journal of Lipid Research|September 3, 2003
12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channelsShih Shen Yiu, Xueying Zhao, Edward W Inscho, et al.
Hypertension (Dallas, Tex. : 1979)|August 6, 2003
Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenasesXueying Zhao, David M Pollock, Darryl C Zeldin, et al.
Expert Reviews in Molecular Medicine|March 2, 2011
Cytochrome P450 eicosanoids and cerebral vascular functionJohn D Imig, Alexis N Simpkins, Marija Renic, et al.
Current Opinion in Nephrology and Hypertension|November 30, 2021
Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosisKate C Chiang, John D Imig, Kamyar Kalantar-Zadeh, et al.
American Journal of Hypertension|March 7, 2014
Azilsartan improves glycemic status and reduces kidney damage in zucker diabetic fatty ratsMd Abdul Hye Khan, Jan Neckář, Jasmine Haines, et al.
Journal of Hypertension|May 6, 2004
Elevated arterial pressure impairs autoregulation independently of AT(1) receptor activationEdward W Inscho, Anthony K Cook, James B Murzynowski, et al.
Hypertension (Dallas, Tex. : 1979)|January 18, 2006
Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertensionAhmed A Elmarakby, Jeffrey E Quigley, David M Pollock, et al.
Pageof 20